Skip to Content

M T15 (Topiramate 200 mg)

Pill imprint M T15 has been identified as Topiramate 200 mg.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; bulimia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate 200 mg M T15
Topiramate 200 mg M T15
Discount Card Promo
Topiramate
Imprint:
M T15
Strength:
200 mg
Color:
White
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-6105
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide